Accurate Activated Clotting Time
(ACT) testing is essential for monitoring
heparin therapy during cardiac procedures.
Actalyke instruments and reagent tubes
provide the sensitivity, reliability and rapidity
needed for timely treatment decisions at the
point of care – in the catheterization lab or
the surgical suite.
The Actalyke XL is a premier analyzer
offering dual-well testing, excellent
reproducibility and strong data handling
features. The Actalyke Mini-II is the
simplest, least expensive instrument available
for activated clotting time testing, yet it
retains high sensitivity with performance,
linearity and CVs that parallel its slightly
larger counterpart.
Both Actalyke instruments use a 2-point
clot detection mechanism, enabling clot
detection at the early fibrin formation stage
with less variation due to clot fragility. This
provides greater precision, especially on
highly heparinized and diluted samples.
Actalyke Mini-II
• Single test well
• 2-point clot detection
• Small 6-inch footprint
• Large, high visibility display
• Simple operation
• Optional battery pack
• Fully compatible with all ACT tubes